Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rakesh Dixit

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
Toxicological Sciences : an Official Journal of the Society of Toxicology|August 21, 2009
Investigations of the use of bioavailability data to adjust occupational exposure limits for active pharmaceutical ingredientsBruce D Naumann, Patricia A Weideman, Ramesh Sarangapani, et al.
Cureus|March 20, 2026
Natural Polyphenols Versus Standard Therapy: Effects on Neuroinflammation and Alpha-Synuclein Expression in a 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP)-Induced Mouse Model of Parkinson's DiseaseShalini Singh, Karan Suneja, Ipshita Jain, et al.
Carcinogenesis|May 10, 2005
The effects of L-748706, a selective cyclooxygenase-2 inhibitor, on N-nitrosomethylbenzylamine-induced rat esophageal tumorigenesisGary D Stoner, Haiyan Qin, Tong Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 14, 2019
Antibody-Drug Conjugates: Future Directions in Clinical and Translational Strategies to Improve the Therapeutic IndexSteven Coats, Marna Williams, Benjamin Kebble, et al.
Toxicologic Pathology|September 15, 2010
Nasal turbinate enlargement due to cartilage and bone proliferation: a normal developmental finding in young ferretsKathleen A Funk, Christopher Frantz, Amy S Dyke, et al.
Cureus|April 20, 2026
Adverse Drug Reactions to Antihypertensive Therapy: A Prospective Evaluation of Causality and Severity Using the World Health Organization-Uppsala Monitoring Centre (WHO-UMC) and Hartwig-Siegel ScalesKaran Suneja, Shalini Singh, Sarvesh Singh, et al.
Toxicology and Applied Pharmacology|July 17, 2018
Monoclonal antibody targeting of fibroblast growth factor receptor 1c causes cardiac valvulopathy in ratsNicholas Buss, Jean-Martin Lapointe, Lolke de Haan, et al.
British Journal of Pharmacology|October 25, 2019
The enhanced immunopharmacology of VIB4920, a novel Tn3 fusion protein and CD40L antagonist, and assessment of its safety profile in cynomolgus monkeysSimone M Nicholson, Kerry A Casey, Michele Gunsior, et al.
The Oncologist|May 13, 2015
Choice of Starting Dose for Biopharmaceuticals in First-in-Human Phase I Cancer Clinical TrialsAaron R Hansen, Natalie Cook, M Stacey Ricci, et al.
Toxicology and Applied Pharmacology|June 18, 2014
Nonclinical safety of mavrilimumab, an anti-GMCSF receptor alpha monoclonal antibody, in cynomolgus monkeys: relevance for human safetyPatricia C Ryan, Matthew A Sleeman, Marlon Rebelatto, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Toxicological Sciences : an Official Journal of the Society of Toxicology|August 21, 2009
Investigations of the use of bioavailability data to adjust occupational exposure limits for active pharmaceutical ingredientsBruce D Naumann, Patricia A Weideman, Ramesh Sarangapani, et al.
Cureus|March 20, 2026
Natural Polyphenols Versus Standard Therapy: Effects on Neuroinflammation and Alpha-Synuclein Expression in a 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP)-Induced Mouse Model of Parkinson's DiseaseShalini Singh, Karan Suneja, Ipshita Jain, et al.
Carcinogenesis|May 10, 2005
The effects of L-748706, a selective cyclooxygenase-2 inhibitor, on N-nitrosomethylbenzylamine-induced rat esophageal tumorigenesisGary D Stoner, Haiyan Qin, Tong Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 14, 2019
Antibody-Drug Conjugates: Future Directions in Clinical and Translational Strategies to Improve the Therapeutic IndexSteven Coats, Marna Williams, Benjamin Kebble, et al.
Toxicologic Pathology|September 15, 2010
Nasal turbinate enlargement due to cartilage and bone proliferation: a normal developmental finding in young ferretsKathleen A Funk, Christopher Frantz, Amy S Dyke, et al.
Cureus|April 20, 2026
Adverse Drug Reactions to Antihypertensive Therapy: A Prospective Evaluation of Causality and Severity Using the World Health Organization-Uppsala Monitoring Centre (WHO-UMC) and Hartwig-Siegel ScalesKaran Suneja, Shalini Singh, Sarvesh Singh, et al.
Toxicology and Applied Pharmacology|July 17, 2018
Monoclonal antibody targeting of fibroblast growth factor receptor 1c causes cardiac valvulopathy in ratsNicholas Buss, Jean-Martin Lapointe, Lolke de Haan, et al.
British Journal of Pharmacology|October 25, 2019
The enhanced immunopharmacology of VIB4920, a novel Tn3 fusion protein and CD40L antagonist, and assessment of its safety profile in cynomolgus monkeysSimone M Nicholson, Kerry A Casey, Michele Gunsior, et al.
The Oncologist|May 13, 2015
Choice of Starting Dose for Biopharmaceuticals in First-in-Human Phase I Cancer Clinical TrialsAaron R Hansen, Natalie Cook, M Stacey Ricci, et al.
Toxicology and Applied Pharmacology|June 18, 2014
Nonclinical safety of mavrilimumab, an anti-GMCSF receptor alpha monoclonal antibody, in cynomolgus monkeys: relevance for human safetyPatricia C Ryan, Matthew A Sleeman, Marlon Rebelatto, et al.
Pageof 4